{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T04:26:48Z","timestamp":1768883208717,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T00:00:00Z","timestamp":1489622400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009139","name":"DZIF","doi-asserted-by":"crossref","award":["TTU 02 80"],"award-info":[{"award-number":["TTU 02 80"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"crossref"}]},{"name":"ZMMK","award":["CAP8"],"award-info":[{"award-number":["CAP8"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s15010-017-1005-4","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T10:53:14Z","timestamp":1489661594000},"page":"341-347","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Low prevalence of DHFR and DHPS mutations in Pneumocystis jirovecii strains obtained from a German cohort"],"prefix":"10.1007","volume":"45","author":[{"given":"Isabelle","family":"Su\u00e1rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Roderus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edeltraud","family":"van Gumpel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norma","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"F\u00e4tkenheuer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pia","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Plum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8351-2690","authenticated-orcid":false,"given":"Jan","family":"Rybniker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,16]]},"reference":[{"key":"1005_CR1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s150100070041","volume":"28","author":"T Gluck","year":"2000","unstructured":"Gluck T, Geerdes-Fenge HF, Straub RH, Raffenberg M, Lang B, Lode H, et al. Pneumocystis carinii pneumonia as a complication of immunosuppressive therapy. Infection. 2000;28:227\u201330.","journal-title":"Infection"},{"key":"1005_CR2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7326\/0003-4819-100-5-663","volume":"100","author":"JA Kovacs","year":"1984","unstructured":"Kovacs JA, Hiemenz JW, Macher AM, Stover D, Murray HW, Shelhamer J, et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med. 1984;100:663\u201371.","journal-title":"Ann Intern Med"},{"key":"1005_CR3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1086\/344951","volume":"36","author":"DT Fisk","year":"2003","unstructured":"Fisk DT, Meshnick S, Kazanjian PH. Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome. Clin Infect Dis. 2003;36:70\u20138.","journal-title":"Clin Infect Dis"},{"key":"1005_CR4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3109\/00365548.2013.777778","volume":"45","author":"JM Llibre","year":"2013","unstructured":"Llibre JM, Revollo B, Vanegas S, Lopez-Nunez JJ, Ornelas A, Marin JM, et al. Pneumocystis jirovecii pneumonia in HIV-1-infected patients in the late-HAART era in developed countries. Scand J Infect Dis. 2013;45:635\u201344.","journal-title":"Scand J Infect Dis"},{"key":"1005_CR5","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1093\/jac\/dkw155","volume":"71","author":"C Cordonnier","year":"2016","unstructured":"Cordonnier C, Cesaro S, Maschmeyer G, Einsele H, Donnelly JP, Alanio A, et al. Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71:2379\u201385.","journal-title":"J Antimicrob Chemother"},{"key":"1005_CR6","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1128\/AAC.42.5.995","volume":"42","author":"JA Fishman","year":"1998","unstructured":"Fishman JA. Prevention of infection due to Pneumocystis carinii. Antimicrob Agents Chemother. 1998;42:995\u20131004.","journal-title":"Antimicrob Agents Chemother"},{"key":"1005_CR7","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1469-0691.2009.03030.x","volume":"16","author":"F Esteves","year":"2010","unstructured":"Esteves F, Gaspar J, Marques T, Leite R, Antunes F, Mansinho K, et al. Identification of relevant single-nucleotide polymorphisms in Pneumocystis jirovecii: relationship with clinical data. Clin Microbiol Infect. 2010;16:878\u201384.","journal-title":"Clin Microbiol Infect"},{"key":"1005_CR8","first-page":"182","volume":"19","author":"AC Moorman","year":"1998","unstructured":"Moorman AC, Von Bargen JC, Palella FJ, Holmberg SD. Pneumocystis carinii pneumonia incidence and chemoprophylaxis failure in ambulatory HIV-infected patients. HIV outpatient study (HOPS) investigators. JAIDS. 1998;19:182\u20138.","journal-title":"JAIDS"},{"key":"1005_CR9","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1128\/JCM.38.9.3161-3164.2000","volume":"38","author":"T Takahashi","year":"2000","unstructured":"Takahashi T, Hosoya N, Endo T, Nakamura T, Sakashita H, Kimura K, et al. Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy. J Clin Microbiol. 2000;38:3161\u20134.","journal-title":"J Clin Microbiol"},{"key":"1005_CR10","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/S0140-6736(05)77687-X","volume":"351","author":"Q Mei","year":"1998","unstructured":"Mei Q, Gurunathan S, Masur H, Kovacs JA. Failure of co-trimoxazole in Pneumocystis carinii infection and mutations in dihydropteroate synthase gene. Lancet. 1998;351:1631\u20132.","journal-title":"Lancet"},{"key":"1005_CR11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/13693786.2010.505584","volume":"49","author":"AK Tyagi","year":"2011","unstructured":"Tyagi AK, Mirdha BR, Luthra K, Guleria R, Mohan A, Singh UB, et al. Pneumocystis jirovecii dihydropteroate synthase (DHPS) genotypes in non-HIV-immunocompromised patients: a tertiary care reference health centre study. Med Mycol. 2011;49:167\u201371.","journal-title":"Med Mycol"},{"key":"1005_CR12","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1086\/500019","volume":"42","author":"D Riebold","year":"2006","unstructured":"Riebold D, Fritzsche C, Lademann M, Bier A, Reisinger EC. Pneumocystis jiroveci dihydropteroate synthase gene mutations at codon 171 but not at codons 55 or 57 detected in Germany. Clin Infect Dis. 2006;42:582\u20133.","journal-title":"Clin Infect Dis"},{"key":"1005_CR13","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1086\/378239","volume":"188","author":"A Nahimana","year":"2003","unstructured":"Nahimana A, Rabodonirina M, Zanetti G, Meneau I, Francioli P, Bille J, et al. Association between a specific Pneumocystis jiroveci dihydropteroate synthase mutation and failure of pyrimethamine\/sulfadoxine prophylaxis in human immunodeficiency virus-positive and negative patients. J Infect Dis. 2003;188:1017\u201323.","journal-title":"J Infect Dis"},{"key":"1005_CR14","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1128\/AAC.01161-13","volume":"57","author":"SF Queener","year":"2013","unstructured":"Queener SF, Cody V, Pace J, Torkelson P, Gangjee A. Trimethoprim resistance of dihydrofolate reductase variants from clinical isolates of Pneumocystis jirovecii. Antimicrob Agents Chemother. 2013;57:4990\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"1005_CR15","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1128\/JCM.02102-08","volume":"47","author":"SJ Hal van","year":"2009","unstructured":"van Hal SJ, Gilgado F, Doyle T, Barratt J, Stark D, Meyer W, et al. Clinical significance and phylogenetic relationship of novel Australian Pneumocystis jirovecii genotypes. J Clin Microbiol. 2009;47:1818\u201323.","journal-title":"J Clin Microbiol"},{"key":"1005_CR16","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(99)03320-6","volume":"354","author":"J Helweg-Larsen","year":"1999","unstructured":"Helweg-Larsen J, Benfield TL, Eugen-Olsen J, Lundgren JD, Lundgren B. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet. 1999;354:1347\u201351.","journal-title":"Lancet"},{"key":"1005_CR17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(01)05705-1","volume":"358","author":"TR Navin","year":"2001","unstructured":"Navin TR, Beard CB, Huang L, del Rio C, Lee S, Pieniazek NJ, et al. Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P. carinii pneumonia in patients with HIV-1: a prospective study. Lancet. 2001;358:545\u20139.","journal-title":"Lancet"},{"key":"1005_CR18","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1086\/340220","volume":"185","author":"L Ma","year":"2002","unstructured":"Ma L, Kovacs JA, Cargnel A, Valerio A, Fantoni G, Atzori C. Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis. J Infect Dis. 2002;185:1530\u20132.","journal-title":"J Infect Dis"},{"key":"1005_CR19","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1177\/1060028016650107","volume":"50","author":"LJ Avino","year":"2016","unstructured":"Avino LJ, Naylor SM, Roecker AM. Pneumocystis jirovecii pneumonia in the non-HIV-infected population. Ann Pharmacother. 2016;50:673\u20139.","journal-title":"Ann Pharmacother"},{"key":"1005_CR20","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/infdis\/175.2.482","volume":"175","author":"BR Lane","year":"1997","unstructured":"Lane BR, Ast JC, Hossler PA, Mindell DP, Bartlett MS, Smith JW, et al. Dihydropteroate synthase polymorphisms in Pneumocystis carinii. J Infect Dis. 1997;175:482\u20135.","journal-title":"J Infect Dis"},{"key":"1005_CR21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3347\/kjp.2015.53.3.321","volume":"53","author":"SM Lee","year":"2015","unstructured":"Lee SM, Cho YK, Sung YM, Chung DH, Jeong SH, Park JW, et al. A case of pneumonia caused by Pneumocystis jirovecii resistant to trimethoprim\u2013sulfamethoxazole. Korean J Parasitol. 2015;53:321\u20137.","journal-title":"Korean J Parasitol"},{"key":"1005_CR22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/jmbi.1996.0770","volume":"266","author":"GE Dale","year":"1997","unstructured":"Dale GE, Broger C, D\u2019Arcy A, Hartman PG, DeHoogt R, Jolidon S, et al. A single amino acid substitution in Staphylococcus aureus dihydrofolate reductase determines trimethoprim resistance. J Mol Biol. 1997;266:23\u201330.","journal-title":"J Mol Biol"},{"key":"1005_CR23","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4269\/ajtmh.2003.68.586","volume":"68","author":"I Khalil","year":"2003","unstructured":"Khalil I, Ronn AM, Alifrangis M, Gabar HA, Satti GM, Bygbjerg IC. Dihydrofolate reductase and dihydropteroate synthase genotypes associated with in vitro resistance of Plasmodium falciparum to pyrimethamine, trimethoprim, sulfadoxine, and sulfamethoxazole. Am J Trop Med Hyg. 2003;68:586\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"1005_CR24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3201\/eid0603.000306","volume":"6","author":"CB Beard","year":"2000","unstructured":"Beard CB, Carter JL, Keely SP, Huang L, Pieniazek NJ, Moura IN, et al. Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis. 2000;6:265\u201372.","journal-title":"Emerg Infect Dis"},{"key":"1005_CR25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.diagmicrobio.2013.01.018","volume":"76","author":"S Gal Le","year":"2013","unstructured":"Le Gal S, Robert-Gangneux F, Perrot M, Rouille A, Virmaux M, Damiani C, et al. Absence of Pneumocystis dihydropteroate synthase mutants in Brittany France. Diagn Microbiol Infect Dis. 2013;76:113\u20135.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1005_CR26","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1086\/655145","volume":"51","author":"PM Hauser","year":"2010","unstructured":"Hauser PM, Nahimana A, Taffe P, Weber R, Francioli P, Bille J, et al. Interhuman transmission as a potential key parameter for geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations. Clin Infect Dis. 2010;51:e28\u201333.","journal-title":"Clin Infect Dis"},{"key":"1005_CR27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3109\/13693786.2011.607474","volume":"50","author":"Y Armas de","year":"2012","unstructured":"de Armas Y, Friaza V, Capo V, Durand-Joly I, Govin A, de la Horra C, et al. Low genetic diversity of Pneumocystis jirovecii among Cuban population based on two-locus mitochondrial typing. Med Mycol. 2012;50:417\u201320.","journal-title":"Med Mycol"},{"key":"1005_CR28","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3109\/13693786.2011.593051","volume":"50","author":"J Beser","year":"2012","unstructured":"Beser J, Dini L, Botero-Kleiven S, Krabbe M, Lindh J, Hagblom P. Absence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii isolated from Swedish patients. Med Mycol. 2012;50:320\u20133.","journal-title":"Med Mycol"},{"key":"1005_CR29","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1086\/315148","volume":"180","author":"L Ma","year":"1999","unstructured":"Ma L, Borio L, Masur H, Kovacs JA. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim\u2013sulfamethoxazole or dapsone use. J Infect Dis. 1999;180:1969\u201378.","journal-title":"J Infect Dis"},{"key":"1005_CR30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijid.2016.03.018","volume":"46","author":"AL Bienvenu","year":"2016","unstructured":"Bienvenu AL, Traore K, Plekhanova I, Bouchrik M, Bossard C, Picot S. Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients. Int J Infect Dis. 2016;46:11\u20137.","journal-title":"Int J Infect Dis"},{"key":"1005_CR31","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s15010-014-0660-y","volume":"42","author":"P Nickel","year":"2014","unstructured":"Nickel P, Schurmann M, Albrecht H, Schindler R, Budde K, Westhoff T, et al. Clindamycin\u2013primaquine for Pneumocystis jiroveci pneumonia in renal transplant patients. Infection. 2014;42:981\u20139.","journal-title":"Infection"},{"key":"1005_CR32","first-page":"CD005590","volume":"10","author":"A Stern","year":"2014","unstructured":"Stern A, Green H, Paul M, Vidal L, Leibovici L. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev. 2014;10:CD005590\u20135.","journal-title":"Cochrane Database Syst Rev"},{"key":"1005_CR33","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1093\/jac\/dkw157","volume":"71","author":"J Maertens","year":"2016","unstructured":"Maertens J, Cesaro S, Maschmeyer G, Einsele H, Donnelly JP, Alanio A, et al. ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71:2397\u2013404.","journal-title":"J Antimicrob Chemother"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-017-1005-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-017-1005-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-017-1005-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T23:59:02Z","timestamp":1601769542000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-017-1005-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,16]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["1005"],"URL":"https:\/\/doi.org\/10.1007\/s15010-017-1005-4","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,16]]}}}